| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Marina Epstein, Jennifer A Bailey, Madeline Furlong, Christine M Steeger, Karl G Hil. An intergenerational investigation of the associations between parental marijuana use trajectories and child functioning. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. vol 34. issue 8. 2021-04-05. PMID:31497987. |
analyses linked parent marijuana use trajectories estimated in a previous publication (epstein et al., 2015) to child marijuana, alcohol, and nicotine use; promarijuana norms; internalizing; externalizing; attention problems; and grades using multilevel modeling among children ages 6 to 21. |
2021-04-05 |
2023-08-13 |
Not clear |
| T Miladinovic, L A Manwell, E Raaphorst, S L Malecki, S A Rana, P E Malle. Effects of chronic nicotine exposure on Δ Pharmacology, biochemistry, and behavior. vol 194. 2021-03-30. PMID:32353393. |
effects of chronic nicotine exposure on Δ high rates of comorbid tobacco and cannabis use in adolescents and young adults may be related to functional interactions between the nicotinic cholinergic and cannabinoid systems in the brain during development. |
2021-03-30 |
2023-08-13 |
Not clear |
| Cashen M Boccio, Dylan B Jackson, Wanda E Lea. Nicotine and marijuana attitudes among flavor-only vaping youth: New evidence from Monitoring the Future. Addictive behaviors. vol 102. 2021-01-12. PMID:31731050. |
nicotine and marijuana attitudes among flavor-only vaping youth: new evidence from monitoring the future. |
2021-01-12 |
2023-08-13 |
Not clear |
| Hayley H A Thorpe, Shahnaza Hamidullah, Bryan W Jenkins, Jibran Y Khokha. Adolescent neurodevelopment and substance use: Receptor expression and behavioral consequences. Pharmacology & therapeutics. vol 206. 2020-12-11. PMID:31706976. |
alcohol, cannabis, nicotine, and opioids all produce marked changes in the expression and function of the neurotransmitter and receptor systems with which they interact. |
2020-12-11 |
2023-08-13 |
Not clear |
| Kenneth Blum, Peter K Thanos, Marlene Oscar-Berman, Marcelo Febo, David Baron, Rajendra D Badgaiyan, Eliot Gardner, Zsolt Demetrovics, Claudia Fahlke, Brett C Haberstick, Kristina Dushaj, Mark S Gol. Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction. Journal of reward deficiency syndrome. vol 1. issue 3. 2020-10-01. PMID:27398406. |
david nutt and associates eloquently proposed that dopamine (da) may be central to psycho stimulant dependence and some what important for alcohol, but not important for opiates, nicotine or even cannabis. |
2020-10-01 |
2023-08-13 |
Not clear |
| Eva Ceskova, Petr Silha. Novel treatment options in depression and psychosis. Neuropsychiatric disease and treatment. vol 14. 2020-10-01. PMID:29559781. |
new treatment options not yet available include cannabidiol, glutamate modulators, and nicotine receptors agonists. |
2020-10-01 |
2023-08-13 |
Not clear |
| Ylenia Duca, Antonio Aversa, Rosita Angela Condorelli, Aldo Eugenio Calogero, Sandro La Vigner. Substance Abuse and Male Hypogonadism. Journal of clinical medicine. vol 8. issue 5. 2020-10-01. PMID:31121993. |
other substances such as nicotine, cannabis, and amphetamines alter spermatogenesis inducing oxidative stress and subsequent apoptosis in testicular tissue. |
2020-10-01 |
2023-08-13 |
Not clear |
| B William Downs, Kenneth Blum, David Baron, Abdalla Bowirrat, Lisa Lott, Raymond Brewer, Brent Boyett, David Siwicki, A Kenison Roy, Arwen Podesta, Sampada Badgaiyan, Raju Hajela, Lyle Fried, Rajendra D Badgaiya. Death by Opioids: Are there non-addictive scientific solutions? Journal of systems and integrative neuroscience. vol 5. 2020-10-01. PMID:31824737. |
the human brain has not been designed to carve out specific drugs like opioids, alcohol, nicotine, cocaine, benzodiazepines or cannabis and process addictions such as gambling as distinct endophenotypes. |
2020-10-01 |
2023-08-13 |
human |
| K Blum, M Febo, R D Badgaiya. Fifty Years in the Development of a Glutaminergic-Dopaminergic Optimization Complex (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome: A Pictorial. Austin addiction sciences. vol 1. issue 2. 2020-09-30. PMID:27840857. |
the food and drug administration (fda) has approved some medication-assisted treatments (mats) for alcoholism, opiate and nicotine dependence, but nothing for psychostimulant and cannabis abuse. |
2020-09-30 |
2023-08-13 |
Not clear |
| Sarah C Akerman, Mary F Brunette, Douglas L Noordsy, Alan I Gree. Pharmacotherapy of Co-Occurring Schizophrenia and Substance Use Disorders. Current addiction reports. vol 1. issue 4. 2020-09-29. PMID:27226947. |
randomized, controlled trials provide some support for use of the atypical antipsychotic clozapine for co-occurring cannabis use disorder, naltrexone and disulfiram for alcohol use disorder, and also nicotine replacement therapy, sustained-release bupropion and varenicline for tobacco use disorder. |
2020-09-29 |
2023-08-13 |
Not clear |
| Neal Doran, Mark G Myers, John Correa, David R Strong, Lyric Tully, Kim Pulver. Marijuana use among young adult non-daily cigarette smokers over time. Addictive behaviors. vol 95. 2020-09-28. PMID:30875533. |
recent data regarding growth in concurrent use of nicotine and marijuana have raised concern that reductions in legal restrictions on marijuana use may increase risk for tobacco-related harms. |
2020-09-28 |
2023-08-13 |
human |
| Shawn Y Forrester, Nusrat Jaha. Depression Onset in Long-term Adolescent Cannabinoid Use: A Neurobiological Review. Cureus. vol 12. issue 4. 2020-09-28. PMID:32455076. |
data were included from studies that satisfied the following criteria: (i) published within the last 10 years (older studies were included based on relevance), (ii) on adolescent subjects (animal or human), (iii) published in english, (iv) journal articles, systematic reviews, meta-analyses, clinical trials, observational studies (animal or human), (v) on subjects who had unipolar depression with no comorbidities, and (vi) on subjects who used cannabis [with no confounding variables such as the use of ethanol, nicotine, cocaine, lysergic acid diethylamide (lsd), and heroin; and no medical conditions such as comorbid psychosis, mania, or autism]. |
2020-09-28 |
2023-08-13 |
human |
| Kyle J Rutledge, Dianne L Plat. Acute Psychosis in Withdrawal from Nicotine Vaping in a Young Man with Comorbid Diabetic Ketoacidosis and Cannabis Use. Case reports in psychiatry. vol 2020. 2020-09-28. PMID:32566348. |
the current report presents the case of a young man with multiple medical comorbidities, including insulin-dependent diabetes mellitus on an insulin pump and presumed gilbert's disease, and chronic cannabis use who experienced acute agitation with hallucinations in the context of quitting his vape pen "cold turkey" or abruptly discontinuing use without a nicotine replacement. |
2020-09-28 |
2023-08-13 |
Not clear |
| David G Gilbert, Norka E Rabinovich, Justin T McDanie. Nicotine patch for cannabis withdrawal symptom relief: a randomized controlled trial. Psychopharmacology. vol 237. issue 5. 2020-09-15. PMID:32034447. |
given that tetrahydrocannabinol (thc) and nicotine have similar effects on negative affect (na), we hypothesized that a 7-mg nicotine patch (np) would reduce na-related cannabis (can) withdrawal symptoms in cannabis-dependent (cd) individuals who were not nicotine dependent. |
2020-09-15 |
2023-08-13 |
Not clear |
| Raghunath Singh, Yashika Bansal, Ishwar Parhar, Anurag Kuhad, Tomoko Sog. Neuropsychiatric implications of transient receptor potential vanilloid (TRPV) channels in the reward system. Neurochemistry international. vol 131. 2020-09-03. PMID:31494132. |
recent evidence has highlighted trpv channels as potential targets for understanding modulation of the reward system and various forms of addiction (opioids, cocaine, amphetamines, alcohol, nicotine, cannabis). |
2020-09-03 |
2023-08-13 |
Not clear |
| Luisa Ponzoni, Milena Moretti, Daniela Braida, Michele Zoli, Francesco Clementi, Paola Viani, Mariaelvina Sala, Cecilia Gott. Increased sensitivity to Δ European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 29. issue 4. 2020-06-17. PMID:30773388. |
in order to study whether the nicotine delivered via e-cig acts as "a gateway drug" to the use of cannabis, we analysed the behavioural and molecular effects of 7 weeks' pre-exposure to air (air), e-cigs or cigs on addiction-related conditioned place preference (cpp) in mice using a sub-threshold (0.01 mg/kg) dose of delta-9-tetrahydrocannabinol (Δ |
2020-06-17 |
2023-08-13 |
mouse |
| Mariel S Bello, Rubin Khoddam, Matthew D Stone, Junhan Cho, Yoewon Yoon, Jungeun Olivia Lee, Adam M Leventha. Poly-product drug use disparities in adolescents of lower socioeconomic status: Emerging trends in nicotine products, marijuana products, and prescription drugs. Behaviour research and therapy. vol 115. 2020-04-14. PMID:30558744. |
poly-product drug use disparities in adolescents of lower socioeconomic status: emerging trends in nicotine products, marijuana products, and prescription drugs. |
2020-04-14 |
2023-08-13 |
Not clear |
| Brian J Fairman, C Debra Furr-Holden, Renee M Johnso. When Marijuana Is Used before Cigarettes or Alcohol: Demographic Predictors and Associations with Heavy Use, Cannabis Use Disorder, and Other Drug-related Outcomes. Prevention science : the official journal of the Society for Prevention Research. vol 20. issue 2. 2020-03-18. PMID:29770947. |
then, we examined whether using marijuana first predicted heavy marijuana use, cannabis use disorder (cud), alcohol use disorder (aud), nicotine dependence (nd), or lifetime use of other illegal drugs. |
2020-03-18 |
2023-08-13 |
Not clear |
| Sara de la Salle, Lawrence Inyang, Danielle Impey, Dylan Smith, Joelle Choueiry, Renee Nelson, Jasmit Heera, Ashley Baddeley, Vadim Ilivitsky, Verner Knot. Acute separate and combined effects of cannabinoid and nicotinic receptor agonists on MMN-indexed auditory deviance detection in healthy humans. Pharmacology, biochemistry, and behavior. vol 184. 2020-02-26. PMID:31283908. |
the high prevalence of concomitant cannabis and nicotine use has implications for sensory and cognitive processing. |
2020-02-26 |
2023-08-13 |
Not clear |
| Natalia Estévez-Lamorte, Simon Foster, Dominique Eich-Höchli, Franz Moggi, Gerhard Gmel, Meichun Mohler-Ku. Adult attention-deficit/hyperactivity disorder, risky substance use and substance use disorders: a follow-up study among young men. European archives of psychiatry and clinical neuroscience. vol 269. issue 6. 2020-02-04. PMID:30483874. |
we examined: (1) the contribution of adhd, as assessed at baseline, on the risky use of alcohol, nicotine and cannabis, and their corresponding use disorders (aud, nud, cud) at follow-up; and (2) the association between adhd and the course of outcomes (i.e., absence, initiation, maturing out, persistence) over 15 months. |
2020-02-04 |
2023-08-13 |
Not clear |